Werkgroep Cardiologische centra Nederland
Menu

PIONEER (Completed)

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Medicine
rivaroxaban
Population
Arrhythmia
Phase
IIIb
Starting year
2012
More information
ClinicalTrials.gov

Director of Study

dr. E. Ronner (Cardioloog)
Delft, Reinier de Graaf Gasthuis

Publications: PIONEER

  • An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCIAHA 2016 - PIONEER - Arrhythmia
  • Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCIN Engl J Med - PIONEER - Arrhythmia

Publications by WCN study

Publications WCN studies by WCN member